A bacterially expressed particulate hepatitis E vaccine: Antigenicity, immunogenicity and protectivity on primates

Vaccine

Volumn 23, Issue 22, 2005, Pages 2893-2901

  Li, Shao W ^a   Zhang, Jun ^a   Li, Yi M ^b   Ou, Shan H ^a   Huang, Guo Y ^c   He, Zhi Q ^a   Ge, Sheng X ^a   Xian, Yang L ^b   Pang, Shu Q ^b   Ng, Mun H ^a   Xia, Ning S ^a  

^a XIAMEN UNIVERSITY   (China)

^b Beijing Wantai Biological Pharmacy Enterprise Co Ltd   (China)

^c Center of Disease Control   (China)

Author keywords

Efficacy; Hepatitis E virus; Particulate; Pre clinical; Vaccine

Indexed keywords

ADJUVANT; ALUMINUM POTASSIUM SULFATE; AMINO ACID DERIVATIVE; CAPSID PROTEIN; HEPATITIS E VIRUS 239 VACCINE; HEPATITIS VACCINE; MONOCLONAL ANTIBODY; MONOMER; PEPTIDE; PEPTIDE DERIVATIVE; RECOMBINANT PEPTIDE E2; RECOMBINANT VACCINE; UNCLASSIFIED DRUG; VIRUS VACCINE;

AMINO TERMINAL SEQUENCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY BLOOD LEVEL; ANTIBODY RESPONSE; ANTIGENICITY; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; DRUG FORMULATION; GENOME; GENOTYPE; HEATING; HEPATITIS E VIRUS; HOMOLOGOUS RECOMBINATION; HUMAN; IMMUNIZATION; IMMUNOGENICITY; INFECTION PREVENTION; MOUSE; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RHESUS MONKEY; SERUM; VACCINATION; VIRUS INFECTION; VIRUS RECOMBINANT; VIRUS STRAIN;

EID: 20144372894     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2004.11.064     Document Type: Article

References (18)

1. V. Demicheli, and D. Tiberti The effectiveness and safety of hepatitis A vaccine: a systematic review Vaccine 21 19-20 2003 2242 2245
2. R.H. Purcell, and S.U. Emerson Hepatitis E virus D. Knipe P. Howley D. Griffin R. Lamb M. Martin B. Roizman Fields virology fourth ed. 2001 Williams and Wilkins Philadelphia (Lippincott) 3051 3061 [Chapter 89]
3. J.L. Melnick Properties and classification of hepatitis A virus Vaccine 10 Suppl l 1992 S24 S26
4. T.C. Li, Y. Yamakawa, and K. Suzuki Expression and self-assembly of empty virus-like particles of hepatitis E virus J Virol 71 10 1997 7207 7213
5. S.U. Emerson, and R.H. Purcell Hepatitis E virus Rev Med Virol 13 3 2003 145 154
6. S.A. Tsarev, T.S. Tsareva, and S.U. Emerson Successful passive and active immunization of cynomolgus monkeys against hepatitis E Proc Natl Acad Sci USA 91 21 1994 10198 10202
7. S.A. Tsarev, T.S. Tsareva, and S.U. Emerson Recombinant vaccine against hepatitis E: dose response and protection against heterologous challenge Vaccine 15 17-18 1997 1834 1838
8. M. Zhang, S.U. Emerson, and H. Nguyen Recombinant vaccine against hepatitis E: duration of protective immunity in rhesus macaques Vaccine 20 27-28 2002 3285 3291
9. R.H. Purcell, H. Nguyen, and M. Shapiro Pre-clinical immunogenicity and efficacy trial of a recombinant hepatitis E vaccine Vaccine 21 19-20 2003 2607 2615
10. S.W. Im, J.Z. Zhang, and H. Zhuang A bacterially expressed peptide prevents experimental infection of primates by the hepatitis E virus Vaccine 19 27 2001 3726 3732
11. S.X. Ge, J. Zhang, G.Y. Huang, S.Q. Pang, K.J. Zhou, and N.S. Xia The immuno-protect study of a hepatitis E virus ORF2 peptide expressed in E. coli Acta Microbilogica Sinica 43 l 2003 35 42
12. J.Z. Zhang, M.H. Ng, and N.S. Xia Conformational antigenic determinants generated by interactions between a bacterially expressed recombinant peptide of the hepatitis E virus structural protein J Med Virol 64 2 2001 125 132
13. J.Z. Zhang, S.W. Im, and S.H. Lau Occurrence of hepatitis E virus IgM, low avidity IgG serum antibodies, and viremia in sporadic cases of non-A, -B, and -C acute hepatitis J Med Virol 66 1 2002 40 48
14. J. Zhang, S.X. Ge, and G.Y. Huang Evaluation of antibody-based and nucleic acid-based assays for diagnosis of hepatitis E virus infection in a rhesus monkey model J Med Virol 71 4 2003 518 526
15. S.W. Li, J. Zhang, and Z.Q. He The study of aggregate of the ORF2 peptide of hepatitis E virus expressed in Escherichia coli Chin J Biotech 18 4 2002 463 467
16. J. Zhang, Y. Gu, and S.X. Ge Analysis of hepatitis E virus neutralization sites using monoclonal antibodies directed against a virus capsid protein Vaccine 23 2005 2881 2892
17. M. Ferguson, D. Walker, E. Mast, and H. Fields Report of a collaborative study to assess the suitability of a reference reagent for antibodies to hepatitis E virus Biologicals 30 1 2002 43 48
18. R.A. Robinson, W.H. Burgess, and S.U. Emerson Structural characterization of recombinant hepatitis E virus ORF2 proteins in baculovirus-infected insect cells Protein Exp Purif 12 1 1998 75 84